维普中文期刊产品整合服务
16篇 您的检索式:作者名="BOGMAN K"
    题名 作者 年代 出处 被引量
1The role of surfactants in the reversal of active transport mediated by multi- drug resistance proteins 显示文摘BOGMAN K ERNE-BRAND F ALSENZ J 2003J Pharm Sci2003,92,6:1
2HMG-CoA reductase inhib-itors and P-glycoprotein modulation显示文摘Bogman K Peyer AK Trk M 2001Pharmacol2001,132,:1
3The role of surfactants in the reversal of active transoport mediated by multidrug resistance proteins显示文摘Bogman K Erne-Brand F Alsenz J 2003J Pharm Sci2003,92,6:1
4HMG - CoA reductase inhibitors and P - glycoprotein modulation显示文摘Bogman K Peyer A Torok M 2001BrJ Pharmacol2001,132,6:1
5P-glycoprotein and surfactants :effect on intestinal talinolol absorption 显示文摘Bogman K Zysset Y Drewe J 2005Clin Pharmacol Ther2005,77,1:1
6The role of surfactants in the reversal of active transport mediated by muhidrug resistance proteins 显示文摘Bogman K Erne-Brand F Alsenz J 2003J Pharm Sci2003,92,:1
7The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins显示文摘Bogman K Ernebrand F Alsenz J 2003J Pham Sci2003,92,2:1
8The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins显示文摘Bogman K Erne-Brand F Alsenz J 2003J Pharm Sci2003,92,6:1
9P-glyeoprotein and sur- factaets: effect on intestinal talinalol absorption显示文摘Bogman K Zyssel Y Degen L etal Clin Phar- macol Ther0,77,:1
10The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins 显示文摘Bogman K Erne-Brand F Alsenz J 2003J Pharm Sci2003,92,6:1
11The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins显示文摘Bogman K Erne-Brand F Alsenz J 2003J Pharm Sci2003,9296,:1
12HMG-CoA reductase inhibitors and P-glycoprotein modulation 显示文摘Bogman K Peyer AK Torok M 2001Br J Pharmacol2001,132,6:1
13The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins 显示文摘Bogman K Ernebrand F Alsenz J 2003J Pham Sci2003,92,2:1
14P-glycoprotein and surfactants: effect on intestinal talinolol absorption 显示文摘Bogman K Zysset Y Degen L 2005Clinical pharmacology and therapeutics2005,77,1:1
15HMG-CoA reductase inhibitors and P glycoprotein modulation 显示文摘Bogman K Peyer AK Torok M 2001Br J Pharmacol2001,132,6:1
16一个高选择性的强效口服醛固酮合成酶(CYP11B2)抑制剂的临床研究显示文摘原发性醛固酮增多症是难治性高血压的一个常见原因。醛固酮合成酶(aldosterone synthase,AS,由CYP11B2基因编码)在肾上腺合成醛固酮。AS与负责皮质醇生成的11β-羟化酶(由CYP11B1基因编码)有93%同源性。此同源性阻碍了原发性醛固酮增多症的新治疗药物(可选择性抑制醛固酮但不影响皮质醇生成)的研发。Bogman K Schwab D Delporte ML Palermo G Amrein K Mohr S De Vera Mudry MC Brown MJ Ferber P 赵狄 练桂丽 2016中华高血压杂志2016,24,12:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费